Evident Vascular develops IVUS (intravascular ultrasound), an essential diagnostic image-guided therapy tool for the treatment of peripheral arterial and venous disease, enabling intraluminal visualization.

Evident Vascular

Evident Vascular, Inc., is developing an advanced intravascular ultrasound (IVUS) platform technology designed initially for peripheral vascular interventions, with future capability for coronary procedures. Leveraging artificial intelligence (AI) to enable superior image interpretation and streamlined workflows, Evident Vascular’s technology has been designed to expand adoption of IVUS, driving increased market penetration and enabling improved clinical outcomes with faster, more accurate diagnosis and treatment decisions.

Evident Vascular, Inc.

📢 ACC 2024 🗞️

Large prospective RCT demonstrates IVUS-guided DCB intervention in fempop 🦵 disease provides significantly improved clinical outcomes! 

Now if only there was a next generation IVUS platform with better image quality, improved ease of use, and AI-enabled capabilities that clinicians actually wanted to use…

Check out —> Evident Vascular, Inc.  

Cc: Howard Rosen

Scientific Advisory Board Member Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM is the leading author of a new study published in the Journal of Society for Cardiovascular Angiography & Interventions (SCAI). The report underscores the need to broaden the adoption of intravascular ultrasound (#IVUS) in peripheral arterial and deep venous interventions, emphasizing its crucial role in advancing patient care.

Evident Vascular CEO Howard Rosen, Vensana Capital Co-Founder and Managing Partner Justin Klein, MD, JD and Vensana Capital Partner Cynthia Yee shared insights and perspective in a new MedTech Strategist article. Together, they weighed in on the implications of this research and highlighted ongoing efforts to develop an advanced solution that will enable more accurate diagnosis and treatment and provide better clinical outcomes.

“Our aim is to significantly enhance adoption rates by streamlining workflow, improving imaging quality for better interpretation, and integrating AI to simplify the process,” Rosen said. “The driving force of Evident Vascular is to address the existing shortcomings and obstacles that are preventing clinicians from utilizing IVUS to its full potential for the benefit of their patients.” 
 
#MedicalInnovation #CardiovasularHealth #PVD #CVD #intravascularimaging #imageguidedtherapy #startup #medtech

We are #hiring! 
We’re looking for individuals to join our R&D and Quality teams. To find out more about these positions at Evident Vascular check out this link: https://lnkd.in/guJSTXt4

#medtech #IVUS #startup #imaging

Today we announce the establishment of our Scientific Advisory Board. Read press release here: tinyurl.com/2p83zus8

We are proud to have such an esteemed group of clinical experts working with us and providing important guidance and insights as we develop a best-in-class IVUS platform designed to meet the specific needs of the interventionalist. Thank you to Ehrin Armstrong, Venita Chandra, Paul Gagne, Mark Garcia, S. Jay Mathews, MD, MS, FACC, FSCAI, Mahmood Razavi, John Rundback, Peter Schneider, and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM. 

We also are pleased to announce that Bruce Shook  an exceptionally accomplished medtech entrepreneur, has joined our Board of Directors as an independent director.

#VIVA2023 #intravascular #imaging #intravascularimaging #imageguidedtherapy #ultrasound #ivus #peripheral #vascular #coronary #cardiovascular #pvd #cvd #startup #medtech

Introducing Evident Vascular! Today we exit stealth mode with a $35M Series A round from Vensana Capital and are poised to transform the future of #intravascular #imaging. 

We are developing a state-of-the-art intravascular #ultrasound (#IVUS) platform technology designed initially for #peripheral #vascular interventions, with future capability for #coronary procedures. Leveraging artificial intelligence (AI) to enable superior image interpretation and streamlined workflows, our technology is designed to expand the adoption of IVUS.  

Based in Silicon Valley, our founding executive team, Howard Rosen, Patrick Phillips and Danielo Piazza, have deep experience in #peripheral #vascular and #cardiovascular markets. Follow us to hear more about what we are doing and for additional announcements coming soon.

Read our press release and learn more about our company: tinyurl.com/yvw7rzvw
#PVD, #CVD, #intravascularimaging, #imageguidedtherapy, #startup, #medtech

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 20, 2024 8:44 PM	41c33a88
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	b81ed67c
crunchbase profile	general
li profile	general	Aug 20, 2024 8:44 PM	5276bd87
translate crunchbase fundingrounds	general
peers	general	Aug 20, 2024 8:44 PM	bab1a810
news basic	general	Aug 20, 2024 8:44 PM	7ef99bc7
bundesanzeiger	filings
financials download nd	financials
private financials	financials

EVID

COM:EVIDENTVASCULAR

Evident Vascular